id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_jar5aqbcorcbhmotxjgsfxycbe	Markus Alter	Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone	2011	2	.pdf	application/pdf	740	83	54	Additional stimulation of sGC on top of standard treatment with ARB's may offer a new therapeutic investigated the effect of riociguat, alone and in combination with the angiotensin II receptor antagonist (ARB) telmisartan on the progression of DN in diabetic eNOS n = 12), significantly reduced blood pressure versus diabetic controls (117.1 ± 2.2 mmHg; n = 14; p = 0.002 However, the combined treatment led to significantly lower urinary albumin excretion sGC on top of standard treatment with ARB's may offer a new therapeutic approach for patients with diabetic 2Center for Cardiovascular Research, Charité, Campus Mitte, Berlin, 2Center for Cardiovascular Research, Charité, Campus Mitte, Berlin, Germany © 2011 Alter et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Cite this article as: Alter et al.: Additional stimulation of sGC on top of standard treatment with ARB's may offer a new therapeutic approach	./cache/work_jar5aqbcorcbhmotxjgsfxycbe.pdf	./txt/work_jar5aqbcorcbhmotxjgsfxycbe.txt